Pfizer/BioNTech seek full FDA approval for their Covid-19 vaccine
Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the first Covid-19 vaccine in the United States to be assessed for full approval from the FDA. Pfizer’s mRNA two-shot vaccine is currently
Continue Reading